AU2001289981A1 - Use of ip3 kinases for preparing medicines for treating oxidative stress-relateddiseases - Google Patents

Use of ip3 kinases for preparing medicines for treating oxidative stress-relateddiseases

Info

Publication number
AU2001289981A1
AU2001289981A1 AU2001289981A AU8998101A AU2001289981A1 AU 2001289981 A1 AU2001289981 A1 AU 2001289981A1 AU 2001289981 A AU2001289981 A AU 2001289981A AU 8998101 A AU8998101 A AU 8998101A AU 2001289981 A1 AU2001289981 A1 AU 2001289981A1
Authority
AU
Australia
Prior art keywords
relateddiseases
kinases
oxidative stress
preparing medicines
treating oxidative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289981A
Inventor
Denise Emmanuelle Busson
Fabrice Girardot
Veronique Monnier
Anne-Marie Pret
Herve Tricoire
Patricia Vandurka
Jeanine Zahraoui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2001289981A1 publication Critical patent/AU2001289981A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001289981A 2000-09-07 2001-08-31 Use of ip3 kinases for preparing medicines for treating oxidative stress-relateddiseases Abandoned AU2001289981A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0011397 2000-09-07
FR0011397A FR2813612A1 (en) 2000-09-07 2000-09-07 USE OF IP3 KINASES FOR THE PREPARATION OF NEW DRUGS IP3 KINASES AND CORRESPONDING DNA SEQUENCES
PCT/FR2001/002708 WO2002020742A1 (en) 2000-09-07 2001-08-31 Use of ip3 kinases for preparing medicines for treating oxidative stress-related diseases

Publications (1)

Publication Number Publication Date
AU2001289981A1 true AU2001289981A1 (en) 2002-03-22

Family

ID=8854046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289981A Abandoned AU2001289981A1 (en) 2000-09-07 2001-08-31 Use of ip3 kinases for preparing medicines for treating oxidative stress-relateddiseases

Country Status (3)

Country Link
AU (1) AU2001289981A1 (en)
FR (1) FR2813612A1 (en)
WO (1) WO2002020742A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002247060A1 (en) * 2001-01-12 2002-08-06 E.I. Dupont De Nemours And Company Novel inositol polyphosphate kinase genes and uses thereof
US20070292349A1 (en) * 2004-01-28 2007-12-20 Exelixis, Inc. Itpks as Modifiers of the Igfr Pathway and Methods of Use

Also Published As

Publication number Publication date
WO2002020742A1 (en) 2002-03-14
FR2813612A1 (en) 2002-03-08

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001282875A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001284646A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HUP0201187A3 (en) Use of ecteinascidin743 for producing pharmaceutical compositions suitable for treating cancer
AU2002227958A1 (en) Use of moulding compounds for producing treatment devices
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU3896900A (en) Treatment of pain
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU2002218439A1 (en) Apparatus for treating body ailments
AUPQ232599A0 (en) Drug for treating fractures
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
AU2001289981A1 (en) Use of ip3 kinases for preparing medicines for treating oxidative stress-relateddiseases
IL154011A0 (en) Treatment of wounds
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
GB9906808D0 (en) Formulation for treatment of pain
AU2000263936A1 (en) Substance p analogs for the treatment of cancer
AU2001273801A1 (en) Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain
AU2683500A (en) Compositions for the treatment of pain
AU2001264375A1 (en) Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy